Defining the burden of pneumonia in children preventable by vaccination against Haemophilus influenzae type b

Pediatric Infectious Disease Journal

Volumn 18, Issue 12, 1999, Pages 1060-1064

  Levine, Orin S ^a   Lagos, Rosanna ^b,c   Muñoz, Alma ^b   Villaroel, Julia ^d   Alvarez, Ana Maria ^e   Abrego, Paulina ^b   Levine, Myron M ^f  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b Centro para Vacunas en Desarrollo Chile   (Chile)

^c HOSPITAL ROBERTO DEL RÍO   (Chile)

^d Servicio de Psiquiatría Hospital Clínico Dr Félix Búlnes   (Chile)

^e HOSPITAL SAN JUAN DE DIOS   (Chile)

^f University of Maryland School of Medicine Center for Vaccine Development   (United States)

Author keywords

Epidemiology; Haemophilus influenzae; Pneumonia; Vaccine

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ABNORMAL RESPIRATORY SOUND; ARTICLE; BACTERIAL INFECTION; CHILD; CHILE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; HAEMOPHILUS INFLUENZAE TYPE B; HOSPITALIZATION; HUMAN; HUMAN EXPERIMENT; INCIDENCE; INFANT; NORMAL HUMAN; PLEURA EFFUSION; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VACCINATION;

EID: 0032784428     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199912000-00006     Document Type: Article

References (23)

1. WHO. Global Program for Vaccines and Immunizations: The WHO position paper on Haemophilus influenzae type b conjugate vaccines. Wkly Epidemiol Rec 1998;73:64-7.
2. Levine OS, Schwartz B, Pierce NF, Kane M. Development, evaluation and implementation of Hib vaccines for young children in developing countries: current status and priority actions. Pediatr Infect Dis J 1998;17:S95-113.
3. Greenwood B. Epidemiology of acute lower respiratory tract infections, especially those due to Haemophilus influenzae type b, in The Gambia, West Africa. J Infect Dis 1992; 165(Suppl 1):S26-8.
4. Lehmann D. Epidemiology of acute respiratory tract infections, especially those due to Haemophilus influenzae, in Papua New Guinean children. J Infect Dis 1992;165(Suppl 1): S20-5.
5. Lagos R, Horowitz I, Toro J, et al. Large-scale, post-licensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections. Pediatr Infect Dis J 1996;15:216-22.
6. Mulholland K, Hilton S, Adegbola R, et al. Randomized trial of Haemophilus influenzae type b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infants. Lancet 1997;349:1191-7.
7. Black SB, Shinefield HR, Fireman B, Hiatt R, Polen M, Vittinghoff E. Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61 080 children. Pediatr Infect Dis J 1991;10:97-104.
8. Booy R, Hodgson S, Carpenter L, et al. Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T. Lancet 1994; 344:362-6.
9. Santosham M, Wolff M, Reid R, Hohenboken M, et al. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex. N Engl J Med 1991;324:1767-72.
10. Peltola H, Kilpi T, Anttila M. Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines. Lancet 1992; 340:592-4.
11. Levine OS, Schwartz B. The rationale for population-based surveillance for Haemophilus influenzae type b meningitis. Pediatr Infect Dis J 1998;17(Suppl):S195-8.
12. Lehmann D. Epidemiology of acute respiratory tract infections, especially those due to Haemophilus influenzae, in Papua New Guinean children. J Infect Dis 1992;165(Suppl 1):S20-5.
13. Black SB, Shinefield HR, Hiatt RA, Fireman BH. Efficacy of Haemophilus influenzae type b capsular polysaccharide vaccine. Pediatr Infect Dis J 1988;7:149-56.
14. Adams WG, Deaver KA, Cochi SL, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA 1993;269:221-6.
15. Wald ER, Levine MM. Haemophilus influenzae type b pneumonia. Arch Dis Child 1978;53:316-8.
16. Hassan-King M, Adegbola R, Baldeh I, et al. A polymerase chain reaction for the diagnosis of Haemophilus influenzae type b disease in children and its evaluation during a vaccine trial. Pediatr Infect Dis J 1998;17:309-12.
17. Lankinen KS, Salo P, Rapola S, Salo E, Takala AK, Leinonen M. Pneumococcal capsular antigen detection after enrichment culture: an alternative to culture methods in epidemiologic research. Am J Trop Med Hyg 1997;56:211-5.
18. Salo P, Ortqvist A, Leinonen M. Diagnosis of bacteremic pneumococcal pneumonia by amplification of pneumolysin gene fragment in serum. J Infect Dis 1995;171:479-82.
19. Nohynek H, Eskola J, Kleemola M, Jalonen E, Saikku P, Leinonen M. Bacterial antibody assays in the diagnosis of acute lower respiratory tract infection in children. Pediatr Infect Dis J 1995;14:478-84.
20. Manary MJ, Lehmann D, Michael A, et al. Antigenuria in healthy Papua New Guinean children with nasal Haemophilus influenzae type b carriage. Ann Trop Paediatr 1993;13: 385-9.
21. Clemens J, Brenner R, Rao M, Tafari N, Lowe C. Evaluating new vaccines for developing countries: efficacy or effectiveness? JAMA 1996;275:390-7.
22. Shann F. Etiology of severe pneumonia in children in developing countries. Pediatr Infect Dis J 1986;5:247-52.
23. WHO. Acute respiratory infections: a forgotten pandemic. Bull WHO 1998;76(1):101-3.